Stock News

Tompkins Financial Has Lifted Stake in Abbvie Com (ABBV) as Market Valuation Rose; Capital Guardian Trust Company Cut Its Stake in Agios Pharmaceuticals (AGIO) by $3.37 Million as Share Value Declined

Tompkins Financial Corp increased its stake in Abbvie Inc Com (ABBV) by 201.85% based on its latest 2017Q3 regulatory filing with the SEC. Tompkins Financial Corp bought 20,986 shares as the company’s stock rose 6.17% with the market. The institutional investor held 31,383 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $2.79 million, up from 10,397 at the end of the previous reported quarter. Tompkins Financial Corp who had been investing in Abbvie Inc Com for a number of months, seems to be bullish on the $189.34B market cap company. The stock increased 3.22% or $3.7 during the last trading session, reaching $118.6. About 8.83M shares traded or 48.72% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 19, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Capital Guardian Trust Company decreased its stake in Agios Pharmaceuticals Inc (AGIO) by 6.54% based on its latest 2017Q3 regulatory filing with the SEC. Capital Guardian Trust Company sold 51,086 shares as the company’s stock declined 9.11% while stock markets rallied. The institutional investor held 729,714 shares of the health care company at the end of 2017Q3, valued at $48.71 million, down from 780,800 at the end of the previous reported quarter. Capital Guardian Trust Company who had been investing in Agios Pharmaceuticals Inc for a number of months, seems to be less bullish one the $4.45B market cap company. The stock decreased 1.38% or $1.09 during the last trading session, reaching $77.7. About 295,360 shares traded. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) has risen 8.52% since February 19, 2017 and is uptrending. It has underperformed by 8.18% the S&P500.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Abbvie Inc had 78 analyst reports since July 21, 2015 according to SRatingsIntel. Deutsche Bank maintained the stock with “Hold” rating in Monday, July 17 report. The firm earned “Buy” rating on Sunday, October 29 by SunTrust. As per Thursday, November 16, the company rating was maintained by BMO Capital Markets. SunTrust initiated AbbVie Inc. (NYSE:ABBV) rating on Wednesday, July 22. SunTrust has “Buy” rating and $85 target. The stock has “Neutral” rating by UBS on Friday, October 13. Morgan Stanley downgraded the stock to “Equal-Weight” rating in Wednesday, June 8 report. The firm has “Buy” rating by Argus Research given on Friday, February 2. The firm has “Buy” rating by Jefferies given on Friday, January 26. The rating was downgraded by BMO Capital Markets to “Market Perform” on Friday, June 10. Leerink Swann maintained AbbVie Inc. (NYSE:ABBV) on Tuesday, December 5 with “Buy” rating.

Since September 11, 2017, it had 0 insider buys, and 5 insider sales for $25.59 million activity. The insider SALEKI-GERHARDT AZITA sold $705,655. Gosebruch Henry O also sold $1.66 million worth of AbbVie Inc. (NYSE:ABBV) on Monday, October 30. On Monday, December 18 the insider RICHMOND TIMOTHY J. sold $8.57M. Michael Robert A. had sold 6,699 shares worth $589,512.

Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.15, from 1 in 2017Q2. It is negative, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. 189.02M were accumulated by Cap Research Glob Investors. Fincl Advisory Grp Inc holds 3,400 shares or 0.1% of its portfolio. Mu Investments Limited stated it has 0.02% of its portfolio in AbbVie Inc. (NYSE:ABBV). Hemenway Tru Lc holds 31,530 shares. Perkins Coie Trust Company accumulated 1.11% or 23,967 shares. Heritage Investors Mngmt Corporation holds 0.56% in AbbVie Inc. (NYSE:ABBV) or 98,616 shares. Aull Monroe Inv Management holds 1.36% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 29,804 shares. Dt Lc, Pennsylvania-based fund reported 41,169 shares. Blackhill Capital stated it has 203,660 shares. Moreover, Rhumbline Advisers has 0.47% invested in AbbVie Inc. (NYSE:ABBV) for 2.44 million shares. Somerville Kurt F owns 29,150 shares or 0.52% of their US portfolio. Alyeska Grp Ltd Partnership owns 19,294 shares. Argyle Cap Mngmt holds 0.44% in AbbVie Inc. (NYSE:ABBV) or 12,650 shares. Inr Advisory Lc invested in 0.01% or 698 shares. Ipswich Inv Mngmt holds 0.18% or 4,420 shares in its portfolio.

Tompkins Financial Corp, which manages about $632.79M and $422.29 million US Long portfolio, decreased its stake in Ishares Tr Russell 1000 Grw (IWF) by 5,054 shares to 33,248 shares, valued at $4.16 million in 2017Q3, according to the filing. It also reduced its holding in Vanguard Index Fds S&P 500 Etf Shs (VOO) by 3,630 shares in the quarter, leaving it with 29,909 shares, and cut its stake in Altria Group Inc Com (NYSE:MO).

Capital Guardian Trust Company, which manages about $5.75 billion US Long portfolio, upped its stake in Cme Group Inc Cl A (NASDAQ:CME) by 18,019 shares to 552,414 shares, valued at $74.95M in 2017Q3, according to the filing. It also increased its holding in Broadcom Ltd by 7,847 shares in the quarter, for a total of 277,330 shares, and has risen its stake in Hdfc Bank Ltd Adr (NYSE:HDB).

Investors sentiment decreased to 1.21 in Q3 2017. Its down 0.83, from 2.04 in 2017Q2. It fall, as 22 investors sold AGIO shares while 44 reduced holdings. 29 funds opened positions while 51 raised stakes. 44.69 million shares or 0.07% less from 44.72 million shares in 2017Q2 were reported. Geode Cap Ltd Com has 0.01% invested in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) for 365,439 shares. Td Asset Mngmt Inc has invested 0% in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). Peak6 Invests LP has invested 0% in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). Ray Gerald L & Associates Ltd holds 0.25% or 29,465 shares. Brown Advisory holds 0.06% or 291,139 shares in its portfolio. Schwab Charles Investment Mngmt holds 0.01% or 115,995 shares. Moreover, Wells Fargo Mn has 0% invested in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) for 90,989 shares. Zurcher Kantonalbank (Zurich Cantonalbank) owns 1,838 shares. Capital Invsts reported 3.14 million shares. 214,000 are held by Eventide Asset Mgmt Lc. C Worldwide Grp A S accumulated 3,800 shares. Rhenman And Asset Management Ab holds 15,000 shares or 0.13% of its portfolio. Opaleye has invested 3.07% in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO). Price T Rowe Assocs Md holds 0.02% or 1.75M shares. Wellington Mngmt Llp stated it has 0.1% of its portfolio in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO).

Since August 22, 2017, it had 0 insider buys, and 21 selling transactions for $24.80 million activity. $3.71M worth of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) was sold by Schenkein David P. Biller Scott had sold 2,146 shares worth $144,276 on Monday, October 2. Bowden Christopher had sold 6,000 shares worth $390,000. Hoerter Steven L. also sold $1.87 million worth of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) shares. Cantley Lewis Clayton Jr. had sold 4,000 shares worth $227,400 on Tuesday, August 22.

Leave a Reply

Your email address will not be published. Required fields are marked *